ロード中...
Comparative efficacy of indacaterol in chronic obstructive pulmonary disease
Long-acting bronchodilators have been shown to improve multiple clinical outcomes in chronic obstructive pulmonary disease (COPD) including lung function, symptoms, dyspnea, quality of life, and exacerbations. Indacaterol is a novel, inhaled, long-acting β2-agonist providing 24-hour bronchodilation...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3299544/ https://ncbi.nlm.nih.gov/pubmed/22419862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S19805 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|